Table 1 Main histopathological data of the study population.
From: Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis
Parameters | Total (N = 23) |
|---|---|
Airways | |
Tracheobronchial inflammation, n (%) | |
Acute, diffuse | 1 (4.3%) |
Acute, focal | 1 (4.3%) |
Chronic, diffuse | 0 |
Chronic, focal | 1 (4.3%) |
Not available | 20 (87.1%) |
Alveolar space | |
Acute inflammation, n (%) | |
Present, diffuse | 1 (4.3%) |
Present, focal | 5 (21.7%) |
Absent | 17 (74%) |
Chronic inflammation, n (%) | |
Present, diffuse | 1 (4.3%) |
Present, focal | 8 (34.8%) |
Absent | 14 (60.9%) |
Hyaline membrane, n (%) | |
Present, diffuse | 6 (26.1%) |
Present, focal | 1 (4.3%) |
Absent | 16 (69.6%) |
Pneumocyte type II hyperplasia, n (%) | |
Present, diffuse | 2 (8.7%) |
Present, focal | 1 (4.3%) |
Absent | 20 (87%) |
Alveolar wall | |
Chronic inflammation, n (%) | |
Present, diffuse | 4 (17.4%) |
Present, focal | 15 (62.2%) |
Absent | 4 (17.4%) |
Fibrosis, n (%) | |
Present, focal | 11 (47.8%) |
Present, diffuse | 9 (39.1%) |
Absent | 3 (13.1%) |
Vessels, n (%) | |
Vessel congestion | 7 (30.4%) |
Blood extravasation | 6 (26.1%) |
Microthrombi | 1 (4.3%) |
Large thrombi | 3 (13%) |
Other lesions, n (%) | |
Succular emphysema | 6 (26.1%) |
Calcifications | 2 (8.7%) |
Anthracosis | 3 (13%) |
Myofibroblastic foci | 2 (8.7%) |
